Cargando…
Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma
BACKGROUND: The purpose of this study was to evaluate the relationship between preoperative inflammatory markers (neutrophil-lymphocyte ratio and platelet-lymphocyte ratio) and cervical stromal involvement in patients with endometrioid adenocarcinoma. METHODS: We studied 318 patients with endometrio...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3604973/ https://www.ncbi.nlm.nih.gov/pubmed/23525143 http://dx.doi.org/10.2147/OTT.S41711 |
_version_ | 1782263804855320576 |
---|---|
author | Wang, Dan Yang, Jia-Xin Cao, Dong-Yan Wan, Xi-Run Feng, Feng-Zhi Huang, Hui-Fang Shen, Keng Xiang, Yang |
author_facet | Wang, Dan Yang, Jia-Xin Cao, Dong-Yan Wan, Xi-Run Feng, Feng-Zhi Huang, Hui-Fang Shen, Keng Xiang, Yang |
author_sort | Wang, Dan |
collection | PubMed |
description | BACKGROUND: The purpose of this study was to evaluate the relationship between preoperative inflammatory markers (neutrophil-lymphocyte ratio and platelet-lymphocyte ratio) and cervical stromal involvement in patients with endometrioid adenocarcinoma. METHODS: We studied 318 patients with endometrioid adenocarcinoma who underwent comprehensive surgical staging. We used univariate and multivariate analyses of cervical stromal involvement and receiver-operating curves to calculate optimal cutoff values for neutrophil-lymphocyte and platelet-lymphocyte ratios to predict cervical stromal involvement. RESULTS: The presence of cervical stromal involvement was associated with neutrophil-lymphocyte ratio and platelet-lymphocyte ratio (P = 0.009 and P = 0.031, respectively). Multivariate analysis showed that higher neutrophil-lymphocyte and platelet-lymphocyte ratios independently predicted cervical stromal involvement (odds ratio 3.10, 95% confidence interval 1.10–8.76, P = 0.032, and odds ratio 5.27, 95% confidence interval 1.94–14.35, P = 0.001, respectively). At a threshold of 2.01, the neutrophil-lymphocyte ratio was 71.0% sensitive and 63.8% specific for stromal involvement; at a 172.24 threshold, the platelet-lymphocyte ratio was 48.4% sensitive and 88.9% specific. CONCLUSION: Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios can help identify the risk of cervical stromal involvement in patients with endometrial cancer. Evaluating these ratios may help select patients who should be particularly watched and tested for cervical stromal involvement. |
format | Online Article Text |
id | pubmed-3604973 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-36049732013-03-22 Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma Wang, Dan Yang, Jia-Xin Cao, Dong-Yan Wan, Xi-Run Feng, Feng-Zhi Huang, Hui-Fang Shen, Keng Xiang, Yang Onco Targets Ther Original Research BACKGROUND: The purpose of this study was to evaluate the relationship between preoperative inflammatory markers (neutrophil-lymphocyte ratio and platelet-lymphocyte ratio) and cervical stromal involvement in patients with endometrioid adenocarcinoma. METHODS: We studied 318 patients with endometrioid adenocarcinoma who underwent comprehensive surgical staging. We used univariate and multivariate analyses of cervical stromal involvement and receiver-operating curves to calculate optimal cutoff values for neutrophil-lymphocyte and platelet-lymphocyte ratios to predict cervical stromal involvement. RESULTS: The presence of cervical stromal involvement was associated with neutrophil-lymphocyte ratio and platelet-lymphocyte ratio (P = 0.009 and P = 0.031, respectively). Multivariate analysis showed that higher neutrophil-lymphocyte and platelet-lymphocyte ratios independently predicted cervical stromal involvement (odds ratio 3.10, 95% confidence interval 1.10–8.76, P = 0.032, and odds ratio 5.27, 95% confidence interval 1.94–14.35, P = 0.001, respectively). At a threshold of 2.01, the neutrophil-lymphocyte ratio was 71.0% sensitive and 63.8% specific for stromal involvement; at a 172.24 threshold, the platelet-lymphocyte ratio was 48.4% sensitive and 88.9% specific. CONCLUSION: Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios can help identify the risk of cervical stromal involvement in patients with endometrial cancer. Evaluating these ratios may help select patients who should be particularly watched and tested for cervical stromal involvement. Dove Medical Press 2013-03-16 /pmc/articles/PMC3604973/ /pubmed/23525143 http://dx.doi.org/10.2147/OTT.S41711 Text en © 2013 Wang et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research Wang, Dan Yang, Jia-Xin Cao, Dong-Yan Wan, Xi-Run Feng, Feng-Zhi Huang, Hui-Fang Shen, Keng Xiang, Yang Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma |
title | Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma |
title_full | Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma |
title_fullStr | Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma |
title_full_unstemmed | Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma |
title_short | Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma |
title_sort | preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3604973/ https://www.ncbi.nlm.nih.gov/pubmed/23525143 http://dx.doi.org/10.2147/OTT.S41711 |
work_keys_str_mv | AT wangdan preoperativeneutrophillymphocyteandplateletlymphocyteratiosasindependentpredictorsofcervicalstromalinvolvementinsurgicallytreatedendometrioidadenocarcinoma AT yangjiaxin preoperativeneutrophillymphocyteandplateletlymphocyteratiosasindependentpredictorsofcervicalstromalinvolvementinsurgicallytreatedendometrioidadenocarcinoma AT caodongyan preoperativeneutrophillymphocyteandplateletlymphocyteratiosasindependentpredictorsofcervicalstromalinvolvementinsurgicallytreatedendometrioidadenocarcinoma AT wanxirun preoperativeneutrophillymphocyteandplateletlymphocyteratiosasindependentpredictorsofcervicalstromalinvolvementinsurgicallytreatedendometrioidadenocarcinoma AT fengfengzhi preoperativeneutrophillymphocyteandplateletlymphocyteratiosasindependentpredictorsofcervicalstromalinvolvementinsurgicallytreatedendometrioidadenocarcinoma AT huanghuifang preoperativeneutrophillymphocyteandplateletlymphocyteratiosasindependentpredictorsofcervicalstromalinvolvementinsurgicallytreatedendometrioidadenocarcinoma AT shenkeng preoperativeneutrophillymphocyteandplateletlymphocyteratiosasindependentpredictorsofcervicalstromalinvolvementinsurgicallytreatedendometrioidadenocarcinoma AT xiangyang preoperativeneutrophillymphocyteandplateletlymphocyteratiosasindependentpredictorsofcervicalstromalinvolvementinsurgicallytreatedendometrioidadenocarcinoma |